|
1
|
Miller KD, Ostrom QT, Kruchko C, Patil N,
Tihan T, Cioffi G, Fuchs HE, Waite KA, Jemal A, Siegel RL and
Barnholtz-Sloan JS: Brain and other central nervous system tumor
statistics, 2021. CA Cancer J Clin. 71:381–406. 2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Chen R, Smith-Cohn M, Cohen AL and Colman
H: Glioma subclassifications and their clinical significance.
Neurotherapeutics. 14:284–297. 2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Montella L, Cuomo M, Del Gaudio N,
Buonaiuto M, Costabile D, Visconti R, Di Risi T, Vinciguerra R,
Trio F, Ferraro S, et al: Epigenetic alterations in glioblastomas:
Diagnostic, prognostic and therapeutic relevance. Int J Cancer.
153:476–488. 2023.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Kannan S, Murugan AK, Balasubramanian S,
Munirajan AK and Alzahrani AS: Gliomas: Genetic alterations,
mechanisms of metastasis, recurrence, drug resistance, and recent
trends in molecular therapeutic options. Biochem Pharmacol.
201(115090)2022.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Lee Y, Ahn C, Han J, Choi H, Kim J, Yim J,
Lee J, Provost P, Rådmark O, Kim S and Kim VN: The nuclear RNase
III Drosha initiates microRNA processing. Nature. 425:415–419.
2003.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Banelli B, Forlani A, Allemanni G,
Morabito A, Pistillo MP and Romani M: MicroRNA in glioblastoma: An
overview. Int J Genomics. 2017(7639084)2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Murugan AK, Munirajan AK and Alzahrani AS:
MicroRNAs: Modulators of the Ras oncogenes in oral cancer. J Cell
Physiol. 231:1424–1431. 2016.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Dai L, Liang W, Shi Z, Li X, Zhou S, Hu W,
Yang Z and Wang X: Systematic characterization and biological
functions of non-coding RNAs in glioblastoma. Cell Prolif.
56(e13375)2023.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Moore LM, Kivinen V, Liu Y, Annala M,
Cogdell D, Liu X, Liu CG, Sawaya R, Yli-Harja O, Shmulevich I, et
al: Transcriptome and small RNA deep sequencing reveals
deregulation of miRNA biogenesis in human glioma. J Pathol.
229:449–459. 2013.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Behrooz AB, Latifi-Navid H, Nezhadi A,
Świat M, Los M, Jamalpoor Z and Ghavami S: Molecular mechanisms of
microRNAs in glioblastoma pathogenesis. Biochim Biophys Acta Mol
Cell Res. 1870(119482)2023.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Anthiya S, Griveau A, Loussouarn C, Baril
P, Garnett M, Issartel JP and Garcion E: MicroRNA-based drugs for
brain tumors. Trends Cancer. 4:222–238. 2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Yin J, Ge X, Shi Z, Yu C, Lu C, Wei Y,
Zeng A, Wang X, Yan W, Zhang J and You Y: Extracellular vesicles
derived from hypoxic glioma stem-like cells confer temozolomide
resistance on glioblastoma by delivering miR-30b-3p. Theranostics.
11:1763–1779. 2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Lei Q, Yang Y, Zhou W, Liu W, Li Y, Qi N,
Li Q, Wen Z, Ding L, Huang X, et al: MicroRNA-based therapy for
glioblastoma: Opportunities and challenges. Eur J Pharmacol.
938(175388)2023.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Clermont PL, Sun L, Crea F, Thu KL, Zhang
A, Parolia A, Lam WL and Helgason CD: Genotranscriptomic
meta-analysis of the Polycomb gene CBX2 in human cancers: Initial
evidence of an oncogenic role. Br J Cancer. 111:1663–1672.
2014.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Del Gaudio N, Di Costanzo A, Liu NQ, Conte
L, Dell'Aversana C, Bove G, Benedetti R, Montella L, Ciardiello F,
Carafa V, et al: CBX2 shapes chromatin accessibility promoting AML
via p38 MAPK signaling pathway. Mol Cancer. 21(125)2022.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Bilton LJ, Warren C, Humphries RM, Kalsi
S, Waters E, Francis T, Dobrowinski W, Beltran-Alvarez P and Wade
MA: The epigenetic regulatory protein CBX2 promotes mTORC1
signalling and inhibits DREAM complex activity to drive breast
cancer cell growth. Cancers (Basel). 14(3491)2022.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Zhou H, Xiong Y, Liu Z, Hou S and Zhou T:
Expression and prognostic significance of CBX2 in colorectal
cancer: Database mining for CBX family members in malignancies and
vitro analyses. Cancer Cell Int. 21(402)2021.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Gulluoglu S, Tuysuz EC, Sahin M, Kuskucu
A, Kaan Yaltirik C, Ture U, Kucukkaraduman B, Akbar MW, Gure AO,
Bayrak OF and Dalan AB: . Simultaneous miRNA and mRNA transcriptome
profiling of glioblastoma samples reveals a novel set of OncomiR
candidates and their target genes. Brain Res. 1700:199–210.
2018.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Huang T, Yang Y, Song X, Wan X, Wu B,
Sastry N, Horbinski CM, Zeng C, Tiek D, Goenka A, et al: PRMT6
methylation of RCC1 regulates mitosis, tumorigenicity, and
radiation response of glioblastoma stem cells. Mol Cell.
81:1276–1291. 2021.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Dalby B, Cates S, Harris A, Ohki EC,
Tilkins ML, Price PJ and Ciccarone VC: Advanced transfection with
Lipofectamine 2000 reagent: primary neurons, siRNA, and
high-throughput applications. Methods. 33:95–103. 2004.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Liang A, Zhou B and Sun W: Integrated
genomic characterization of cancer genes in glioma. Cancer Cell
Int. 17(90)2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Jonsson P, Lin AL, Young RJ, DiStefano NM,
Hyman DM, Li BT, Berger MF, Zehir A, Ladanyi M, Solit DB, et al:
Genomic correlates of disease progression and treatment response in
prospectively characterized gliomas. Clin Cancer Res. 25:5537–5547.
2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Zuo J, Yu H, Xie P, Liu W, Wang K and Ni
H: miR-454-3p exerts tumor-suppressive functions by down-regulation
of NFATc2 in glioblastoma. Gene. 710:233–239. 2019.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Zhou F, Cao W, Xu R, Zhang J, Yu T, Xu X,
Zhi T, Yin J, Cao S, Liu N, et al: MicroRNA-206 attenuates glioma
cell proliferation, migration, and invasion by blocking the
WNT/β-catenin pathway via direct targeting of Frizzled 7 mRNA. Am J
Transl Res. 11:4584–4601. 2019.PubMed/NCBI
|
|
25
|
Bian Z, Ji W, Xu B, Huo Z, Huang H, Huang
J, Jiao J, Shao J and Zhang X: Noncoding RNAs involved in the STAT3
pathway in glioma. Cancer Cell Int. 21(445)2021.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Chan SH, Huang WC, Chang JW, Chang KJ, Kuo
WH, Wang MY, Lin KY, Uen YH, Hou MF, Lin CM, et al: MicroRNA-149
targets GIT1 to suppress integrin signaling and breast cancer
metastasis. Oncogene. 33:4496–4507. 2014.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Cao D, Jia Z, You L, Wu Y, Hou Z, Suo Y,
Zhang H, Wen S, Tsukamoto T, Oshima M, et al: 18β-glycyrrhetinic
acid suppresses gastric cancer by activation of miR-149-3p-Wnt-1
signaling. Oncotarget. 7:71960–71973. 2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Okato A, Arai T, Yamada Y, Sugawara S,
Koshizuka K, Fujimura L, Kurozumi A, Kato M, Kojima S, Naya Y, et
al: Dual strands of pre-miR-149 inhibit cancer cell migration and
invasion through targeting FOXM1 in renal cell carcinoma. Int J Mol
Sci. 18(1969)2017.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Fan SJ, Li HB, Cui G, Kong XL, Sun LL,
Zhao YQ, Li YH and Zhou J: miRNA-149* promotes cell proliferation
and suppresses apoptosis by mediating JunB in T-cell acute
lymphoblastic leukemia. Leuk Res. 41:62–70. 2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Long C, Jiang L, Wei F, Ma C, Zhou H, Yang
S, Liu X and Liu Z: Integrated miRNA-mRNA analysis revealing the
potential roles of miRNAs in chordomas. PLoS One.
8(e66676)2013.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Kaustov L, Ouyang H, Amaya M, Lemak A,
Nady N, Duan S, Wasney GA, Li Z, Vedadi M, Schapira M, et al:
Recognition and specificity determinants of the human cbx
chromodomains. J Biol Chem. 286:521–529. 2011.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Clermont PL, Crea F, Chiang YT, Lin D,
Zhang A, Wang JZ, Parolia A, Wu R, Xue H, Wang Y, et al:
Identification of the epigenetic reader CBX2 as a potential drug
target in advanced prostate cancer. Clin Epigenetics.
8(16)2016.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Wheeler LJ, Watson ZL, Qamar L, Yamamoto
TM, Post MD, Berning AA, Spillman MA, Behbakht K and Bitler BG:
CBX2 identified as driver of anoikis escape and dissemination in
high grade serous ovarian cancer. Oncogenesis. 7(92)2018.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Jangal M, Lebeau B and Witcher M: Beyond
EZH2: Is the polycomb protein CBX2 an emerging target for
anti-cancer therapy? Expert Opin Ther Targets. 23:565–578.
2019.PubMed/NCBI View Article : Google Scholar
|
